Jun Hu
About Jun Hu
Jun Hu is the Director at Alkermes, with extensive experience in analytical development programs and a strong background in small molecule and biologics analytical development.
Current Role at Alkermes
Jun Hu serves as a Director at Alkermes, where he actively manages analytical development programs. His responsibilities include overseeing the development processes from GLP toxicology studies to Phase I-III clinical trials. Jun joined Alkermes in 2018 as a Principal Scientist and was promoted to Director in 2020.
Previous Role as Principal Scientist at Alkermes
Before being promoted to Director, Jun Hu was a Principal Scientist at Alkermes from 2018 to 2020, based in Waltham. In this role, he played a crucial part in the company's analytical development initiatives, focusing on both small molecule and biologics analytical development.
Experience at Shire
From 2015 to 2018, Jun Hu worked as a Senior Scientist at Shire in Lexington, MA. During his tenure, he gained valuable experience in the pharmaceutical industry's analytical development sector, contributing to several key projects and initiatives.
Educational Background
Jun Hu has a diverse and extensive educational background. He earned his PhD in Biochemistry from Florida State University, where he studied from 1999 to 2005. Prior to that, he completed his Master of Science in Organic Chemistry at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences. He also holds a Bachelor of Science from the Ocean University of China and an MBA from Wilmington University, achieved with a 3.7 GPA.
Early Career Experience
Jun Hu started his professional journey as a Research Fellow at the National Institutes of Health from 2005 to 2008. He then moved to AstraZeneca, where he spent seven years as a Senior Scientist based in Waltham, Massachusetts. His experience spans various roles and organizations, including contract testing laboratories, contract research organizations, and contract development and manufacturing organizations.